Johnathan Ho, MD
Physical Medicine & Rehabilitation · Dearborn, MINPI 1710274386
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,075 of the $2,620 with a category attached, or 79.2%. Ipsen Biopharmaceuticals, Inc accounts for 86.2% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2021 at $2,196 and has fallen 99.0% since, to $23 in 2025.
Across 8 payments — averaging $327.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ipsen Biopharmaceuticals, Inc$2K
- Nevro Corp.$145
- Amgen$125
- Averitas Pharma Inc.$68
- AbbVie$23
Across 32 payments — averaging $1959.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ipsen Pharma SAS$63K
What the payments were for
- Consulting fees$2,07579%
- Food & beverage$54521%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 4 | $2,260 |
| Nevro Corp. | 1 | $145 |
| Amgen | 1 | $125 |
| Averitas Pharma Inc. | 1 | $68 |
| AbbVie | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,620 in reported general payments places this provider in the 85th percentile of 469 physical medicine & rehabilitation providers in Michigan.
See all physical medicine & rehabilitation providers in Michigan →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 89 | $1,157 |
| Baclofen | 34 | $872 |
| Gabapentin | 55 | $665 |
| Diclofenac Sodium | 15 | $593 |
| Pregabalin | 39 | $438 |
| Duloxetine Hcl | 21 | $360 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 27 | $318 |
| Tramadol Hcl | 40 | $298 |
| Donepezil Hcl | 28 | $244 |
| Tizanidine Hcl | 15 | $173 |
| Methocarbamol | 18 | $171 |
| Methadone Hcl | 15 | $108 |
| Sertraline Hcl | 26 | $93 |
| Cyclobenzaprine Hcl | 11 | $89 |
| Meloxicam | 12 | $38 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Dearborn
- In YoonDearborn$10K
- Eduardo J Otero-LoperenaDearborn$8K
- Edward DabrowskiRoseville$167K
- Erika ErlandsonAnn Arbor$54K
- Gianna Maria RodriguezAnn Arbor$41K
- Mathew SaffarianEast Lansing$24K
- Jason PeterTroy$20K
- David WiersemaSaginaw$17K
- Satyum ParikhWarren$11K
- Reginald KapteynMuskegon$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.